MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.

Employees

Sector

Drug Retailers

More about the company

Real-time Euronext Paris 22:30:11 23/10/2019 HKT			5-day change	1st Jan Change
20.20 ^EUR	-.--%		-.--%	+18.82%

10/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI

Market Cap	38.47M 34.45M 31.69M 28.71M 53.67M 3.65B 54.68M 378M 152M 1.92B 144M 141M 6.06B	P/E 2017	17.4x	P/E 2018	19.8x
Enterprise Value	36.72M 32.88M 30.25M 27.41M 51.23M 3.49B 52.19M 361M 145M 1.83B 138M 135M 5.78B	EV / Sales 2017	1.97x	EV / Sales 2018	1.38x
Free-Float	5.42%	Yield 2017	3.36%	Yield 2018	-

10/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI
18/09/19	Curae Lab SARL agreed to acquire remaining 12.5% stake in Millet Innovation SA from Holding Managers for €4.8 million.	CI

25/10/19	Millet Innovation : MILLET INNOVATION - MISE EN OEUVRE DU RETRAIT OBLIGATOIRE
09/10/19	Millet Innovation : Communiqué de mise à disposition des Autres informations
09/10/19	Millet Innovation : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE D’INFORMATION ETABLI PAR CURAE LAB
18/09/19	Millet Innovation : DEPOT PROJET DE NOTE D’INFORMATION EN REPONSE RELATIVE A L’OPAS
18/09/19	Millet Innovation : RAPPORT SEMESTRIEL AU 30/06/2019

Millet Innovation Stock

Stocks

ALINN

FR0010304402

Drug Retailers

Valuation: Millet Innovation

Latest news: Millet Innovation

News in other languages: Millet Innovation

Managers and Directors: Millet Innovation

Retail - Drugs without Grocery

Financials

Company Profile

Manager	Title	Age	Since
Damien Millet CEO	Chief Executive Officer	-	09/12/2002
Valérie Chopinet DFI	Director of Finance/CFO	-	19/12/2006

Director	Title	Age	Since
Jean-Claude Millet CHM	Chairman	-	16/03/1998
Pierre Martin BRD	Director/Board Member	-	16/03/1998
Jean-Paul Maingaud BRD	Director/Board Member	-	31/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MILLET INNOVATION	-.--%	-.--%	-	-	42.79M
JD HEALTH INTERNATIONAL INC.	+5.89%	+1.33%	-37.23%	+7.17%	15.49B
MATSUKIYOCOCOKARA & CO.	+3.15%	-0.76%	-6.75%	-1.29%	6.5B
TSURUHA HOLDINGS INC.	+2.38%	+0.43%	-16.47%	+1.18%	6.44B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+2.54%	-1.40%	-51.29%	-38.72%	5.82B
RAIA DROGASIL S.A.	-17.06%	-24.95%	-22.38%	-39.83%	4.9B
YIFENG PHARMACY CHAIN CO., LTD.	+5.00%	+4.34%	+8.35%	-3.08%	4.82B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+9.99%	+11.56%	+10.83%	-14.87%	3.47B
NAHDI MEDICAL COMPANY	-0.44%	+10.73%	-21.79%	-32.44%	3.16B
SUGI HOLDINGS CO.,LTD.	+1.44%	+3.86%	-21.60%	+28.54%	3.08B
Average	+1.29%	-0.44%	-17.59%	-10.37%	5.37B
Weighted average by Cap.	+2.23%	-0.71%	-22.22%	-7.29%

	2017	2018
Net sales	21.86M 19.58M 18.01M 16.32M 30.5M 2.08B 31.07M 215M 86.2M 1.09B 82.03M 80.29M 3.44B	22.21M 19.89M 18.3M 16.58M 30.99M 2.11B 31.57M 218M 87.59M 1.11B 83.35M 81.58M 3.5B
Net income	2.54M 2.28M 2.09M 1.9M 3.55M 241M 3.61M 24.98M 10.03M 127M 9.54M 9.34M 400M	1.63M 1.46M 1.34M 1.22M 2.28M 155M 2.32M 16.04M 6.44M 81.54M 6.13M 6M 257M
Net Debt	-1.07M -954K -878K -795K -1.49M -101M -1.51M -10.47M -4.2M -53.23M -4M -3.91M -168M	-1.75M -1.57M -1.44M -1.31M -2.44M -166M -2.49M -17.21M -6.91M -87.52M -6.58M -6.44M -276M